2m 2m 2m 2m 2m 2m 2m
TURN THERAPEUTIC (TTRX)
NASDAQ
$5.71-$0.31 (-5.20%)
Price as of Jun 03, 2026 7:59 PM EDT- $154.9MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
TURN THERAPEUTIC (TTRX)
$5.71-$0.31 (-5.20%)
Key Performance
More- Earnings Score: N/A
- Momentum Score: N/A
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreDay Range
$5.51
$6.30
$6.02
1-Year Range
$2.71
$9.20
$6.02
Latest Close$6.02
Change
-$0.40 (-6.64%)
Volume91,501
Market Cap$154.9M
Shares Outstanding29.8M
P/E (TTM)-78.43
Diluted EPS (TTM)-$0.07
Enterprise Value$149.6M
Information as of 06/03/2026
Company Profile
TURN THERAPEUTICS INC
https://turntherapeutics.com$154.9M
Market Cap
-$1.9M
Net Income
Sector: Healthcare
Industry: Biotechnology
250 N Westlake Blvd, Westlake Village, CA, United States, 91362
818 546 4011Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Key Executives
- Bradley E. Burnam
- Zuraiz Chaudhary
- Mohammed Zubair
- Neilesh Shailesh Ghodadra
- Stephen Hahn FASTRO
Current Ownership Distribution
- Other29.2M (98.15%)
- Institutions462,310 (1.55%)
- Mutual Funds88,680 (0.30%)
- Insiders0 (0.00%)